在不可切除的晚期,复发性或转移性食道状细胞癌中使用尼沃卢马布
Go Ikeda1,2, Jun Miyakoshi1, Shun Yamamoto1
1Department of Head & Neck, Esophageal Medical Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Future oncology (London, England)
|December 21, 2023
概括
含尼沃卢马布的治疗方法对晚期食道状细胞癌的生存有好处. 这种免疫治疗方法,包括PD-1阻断,为预后不佳的患者提供了新的希望.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 胃肠道癌症 胃肠道癌症
背景情况:
- 食道癌 (EC) 是全球癌症死亡的主要原因.
- 尽管使用多模式治疗,但晚期EC患者的预后不好.
- 免疫疗法,特别是PD-1/PD-L1和CTLA-4/B7阻断,是一种有前途的癌症治疗方法.
研究的目的:
- 审查含有尼沃卢马布的治疗方法,以治疗晚期食道状细胞癌.
- 为了突出PD-1阻断在食道癌症治疗中的有效性.
主要方法:
- 临床试验的审查,包括吸引-3和CheckMate 648.
- 专注于尼沃卢马布 (抗PD-1) 和伊皮利穆马布 (抗CTLA-4) 疗法.
- 对患有晚期食道状细胞癌的患者的生存益处的分析.
主要成果:
- 尼沃卢马布已批准用于治疗抗,不可切除,复发或转移的食道状细胞癌.
- 检查Mate 648试验显示,尼沃卢马布加化学疗法或尼沃卢马布加伊皮利穆马布的生存益处.
- 与双重化疗相比,组合免疫疗法证明了更好的生存率.
结论:
- 基于尼沃卢马布的疗法在治疗晚期食道状细胞癌方面取得了重大进展.
- 免疫疗法为患有晚期疾病的患者提供了生存优势.
- 对含有尼沃卢马布的疗法进行进一步的研究是有必要的.
关键词:
细胞毒性T淋巴细胞抗原-4这是食道癌的癌症.免疫检查点抑制剂免疫检查点抑制剂这里是 ipilimumab 的所在地.这就是尼沃卢马布 (nivolumab).编程细胞死亡-1-1编程细胞死亡 - - 灵-1更多相关视频
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.5K
06:15Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
27.4K
相关概念视频
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
01:27Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
01:28Esophageal Varices-II: Clinical Features and Management
71
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
71
01:21Barrett Esophagus-II: Clinical Manifestations and Management
157
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
157
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
167
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
167
01:24Esophageal Varices-I: Introduction
146
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
146